Search research articles
Contact Us
Filters
Showing results (1251-1260 of 1,504) with videos related to
Page
of 151
Sort By:
Bioscience
|
September 4, 2024
Safeguarding Earth's biodiversity by creating a lunar biorepository
Mary Hagedorn, Lynne R Parenti, Robert A Craddock, et al.
Cell Stem Cell
|
June 11, 2013
Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease
Abdellatif Benraiss, Michael J Toner, Qiwu Xu, et al.
Physical Review Letters
|
October 4, 2000
Measurement of the 1s-2s energy interval in muonium
Meyer, Bagayev, Baird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors
S M Talbot, D A Westerman, A P Grigg, et al.
Plos One
|
February 24, 2018
Ultra-fast vitrification of patient-derived circulating tumor cell lines
Rebecca D Sandlin, Keith H K Wong, Shannon N Tessier, et al.
Oncology (Williston Park, N.Y.)
|
April 1, 1997
Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand
J F Bishop, J Dewar, G C Toner, et al.
Blood Advances
|
September 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma
Keri Toner, Lindsay A Renfro, Hema Dave, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 13, 2003
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals
Rajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide
Owen A O'Connor, Emily A Smith, Lorraine E Toner, et al.
Cancer
|
January 15, 1997
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group
E W Steyerberg, H J Keizer, J E Messemer, et al.
Page
of 151
Search research articles
Search
Showing results (1251-1260 of 1,504) with videos related to
Sort By:
Page
of 151
Bioscience
|
September 4, 2024
Safeguarding Earth's biodiversity by creating a lunar biorepository
Mary Hagedorn, Lynne R Parenti, Robert A Craddock, et al.
Cell Stem Cell
|
June 11, 2013
Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease
Abdellatif Benraiss, Michael J Toner, Qiwu Xu, et al.
Physical Review Letters
|
October 4, 2000
Measurement of the 1s-2s energy interval in muonium
Meyer, Bagayev, Baird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors
S M Talbot, D A Westerman, A P Grigg, et al.
Plos One
|
February 24, 2018
Ultra-fast vitrification of patient-derived circulating tumor cell lines
Rebecca D Sandlin, Keith H K Wong, Shannon N Tessier, et al.
Oncology (Williston Park, N.Y.)
|
April 1, 1997
Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand
J F Bishop, J Dewar, G C Toner, et al.
Blood Advances
|
September 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma
Keri Toner, Lindsay A Renfro, Hema Dave, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 13, 2003
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals
Rajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide
Owen A O'Connor, Emily A Smith, Lorraine E Toner, et al.
Cancer
|
January 15, 1997
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group
E W Steyerberg, H J Keizer, J E Messemer, et al.
Page
of 151